• Exchange: Stockholm
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

ORX:SS

127.5000 SEK 2.2500 1.73%

As of 11:29:59 ET on 09/12/2014.

Snapshot for Orexo AB (ORX)

Open: 131.0000 Day's Range: 125.5000 - 131.0000 Volume: 207,739
Previous Close: 129.7500 52wk Range: 90.7500 - 183.5000 1-Yr Rtn: +13.59%

Stock Chart for ORX

No chart data available.
  • ORX:SS 127.5000
  • 1D
  • 1M
  • 1Y
129.7500
Interactive ORX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ORX

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. OMX -
Earnings Per Share (SEK) (ttm) -4.3635
Est. EPS (SEK) (12/2014) -2.0960
Est. PEG Ratio -
Market Cap (M SEK) 4,376.46
Shares Outstanding (M) 34.33
30 Day Average Volume 184,779
Price/Book (mrq) 46.4142
Price/Sale (ttm) 9.1530
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 10/22/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ORX

  • Revenue
  • Net Income (M/SEK)
  • Profit Margin (%)

Company Profile & Key Executives for ORX

Orexo AB is a product oriented drug delivery company that develops new pharmaceuticals by further develop existing products. The Company specializes in drugs in tablet form especially sublingual pills and often works together with scientists and other corporations. Orexo sells internationally.

Martin NicklassonChairmanNikolaj SorensenChief Executive Officer
Henrik JuuelExec VP/CFO
More Company Profile & Key Executives for ORX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil